6.35
0.00
(0.00%)
At close: January 30 at 3:29:02 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | -- | 3 | 3 |
| Avg. Estimate | 16.3M | -- | 58.85M | 134.56M |
| Low Estimate | 14.3M | -- | 56.85M | 92.33M |
| High Estimate | 17.74M | -- | 60.3M | 180.53M |
| Year Ago Sales | 20.59M | -- | 84.51M | 58.85M |
| Sales Growth (year/est) | -20.85% | -- | -30.36% | 128.63% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CNB0.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Related Tickers
PSH.DE Sernova Corp.
0.1447
+0.56%
BRNS Barinthus Biotherapeutics plc
1.0953
+9.53%
NFX.L Nuformix plc
0.0700
-6.67%
APLM Apollomics, Inc.
8.50
-1.28%
BCYC Bicycle Therapeutics plc
13.39
+4.86%
VYNE VYNE Therapeutics Inc.
2.3500
-0.42%
ALEC Alector, Inc.
1.6600
-3.49%
IMNN Imunon, Inc.
0.8850
-2.78%
OVID Ovid Therapeutics Inc.
0.6634
-5.24%
ENSC Ensysce Biosciences, Inc.
6.87
+2.42%